Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-08-13

Clinical Trial Update: Clinical Trial Comparing the Efficacy and Safety of DA-3803 and Ovidrel [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing DA-3803 to Ovidrel for hyperovulation induction in assisted reproduction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DA-3803
  • Ovidrel (Choriogonadotropin alfa)

Snippet

Sponsor: Dong-A Pharmaceutical Co., Ltd. | Conditions: Hyperovulation Induction for Assisted Reproduction Treatment | Phase 3 | Status: COMPLETED